Amanda F Petrik1, Beverly Green2, Jennifer Schneider3, Edward J Miech4, Jennifer Coury5, Sally Retecki6, Gloria D Coronado3. 1. Center for Health Research, Kaiser Permanente Northwest, Portland, OR, USA. Amanda.f.petrik@kpchr.org. 2. Health Research Institute, Kaiser Permanente Washington, Seattle, WA, USA. 3. Center for Health Research, Kaiser Permanente Northwest, Portland, OR, USA. 4. Regenstrief Institute, Indianapolis, IN, USA. 5. Oregon Health & Sciences University, Portland, OR, USA. 6. CareOregon Inc., Portland, OR, USA.
Abstract
BACKGROUND: Evidence-based programs such as mailed fecal immunochemical test (FIT) outreach can only affect health outcomes if they can be successfully implemented. However, attempts to implement programs are often limited by organizational-level factors. OBJECTIVES: As part of the Strategies and Opportunities to Stop Colon Cancer in Priority Populations (STOP CRC) pragmatic trial, we evaluated how organizational factors impacted the extent to which health centers implemented a mailed FIT outreach program. DESIGN: Eight health centers participated in STOP CRC. The intervention consisted of customized electronic health record tools and clinical staff training to facilitate mailing of an introduction letter, FIT kit, and reminder letter. Health centers had flexibility in how they delivered the program. MAIN MEASURES: We categorized the health centers' level of implementation based on the proportion of eligible patients who were mailed a FIT kit, and applied configurational comparative methods to identify combinations of relevant organizational-level and program-level factors that distinguished among high, medium, and low implementing health centers. The factors were categorized according to the Consolidated Framework for Implementation Research model. KEY RESULTS: FIT tests were mailed to 21.0-81.7% of eligible participants at each health center. We identified a two-factor solution that distinguished among levels of implementation with 100% consistency and 100% coverage. The factors were having a centralized implementation team (inner setting) and mailing the introduction letter in advance of the FIT kit (intervention characteristics). Health centers with high levels of implementation had the joint presence of both factors. In health centers with medium levels of implementation, only one factor was present. Health centers with low levels of implementation had neither factor present. CONCLUSIONS: Full implementation of the STOP CRC intervention relied on a centralized implementation team with dedicated staffing time, and the advance mailing of an introduction letter. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT01742065 Registered 05 December 2012-Prospectively registered.
BACKGROUND: Evidence-based programs such as mailed fecal immunochemical test (FIT) outreach can only affect health outcomes if they can be successfully implemented. However, attempts to implement programs are often limited by organizational-level factors. OBJECTIVES: As part of the Strategies and Opportunities to Stop Colon Cancer in Priority Populations (STOP CRC) pragmatic trial, we evaluated how organizational factors impacted the extent to which health centers implemented a mailed FIT outreach program. DESIGN: Eight health centers participated in STOP CRC. The intervention consisted of customized electronic health record tools and clinical staff training to facilitate mailing of an introduction letter, FIT kit, and reminder letter. Health centers had flexibility in how they delivered the program. MAIN MEASURES: We categorized the health centers' level of implementation based on the proportion of eligible patients who were mailed a FIT kit, and applied configurational comparative methods to identify combinations of relevant organizational-level and program-level factors that distinguished among high, medium, and low implementing health centers. The factors were categorized according to the Consolidated Framework for Implementation Research model. KEY RESULTS: FIT tests were mailed to 21.0-81.7% of eligible participants at each health center. We identified a two-factor solution that distinguished among levels of implementation with 100% consistency and 100% coverage. The factors were having a centralized implementation team (inner setting) and mailing the introduction letter in advance of the FIT kit (intervention characteristics). Health centers with high levels of implementation had the joint presence of both factors. In health centers with medium levels of implementation, only one factor was present. Health centers with low levels of implementation had neither factor present. CONCLUSIONS: Full implementation of the STOP CRC intervention relied on a centralized implementation team with dedicated staffing time, and the advance mailing of an introduction letter. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT01742065 Registered 05 December 2012-Prospectively registered.
Entities:
Keywords:
Consolidated Framework for Implementation Research; FIT tests; colorectal cancer; configurational comparative methods; fecal immunochemical tests; implementation; screening
Authors: Gloria D Coronado; Amanda F Petrik; Mark Spofford; Jocelyn Talbot; Huyen Hoai Do; Victoria M Taylor Journal: Health Educ Behav Date: 2014-06-20
Authors: Shivan J Mehta; Christopher D Jensen; Virginia P Quinn; Joanne E Schottinger; Ann G Zauber; Reinier Meester; Adeyinka O Laiyemo; Stacey Fedewa; Michael Goodman; Robert H Fletcher; Theodore R Levin; Douglas A Corley; Chyke A Doubeni Journal: J Gen Intern Med Date: 2016-07-13 Impact factor: 5.128
Authors: Beverly B Green; Melissa L Anderson; Andrea J Cook; Jessica Chubak; Sharon Fuller; Richard T Meenan; Sally W Vernon Journal: Cancer Date: 2017-07-28 Impact factor: 6.860
Authors: Kathryn E Kemper; Becky L Glaze; Casey L Eastman; Roxane C Waldron; Sonja Hoover; T'Ronda Flagg; Florence K L Tangka; Sujha Subramanian Journal: Cancer Date: 2018-10-25 Impact factor: 6.860
Authors: David T Liss; Dustin D French; David R Buchanan; Tiffany Brown; Bridget G Magner; Stephanie Kollar; David W Baker Journal: Am J Prev Med Date: 2015-09-09 Impact factor: 5.043
Authors: Gloria D Coronado; Amanda F Petrik; William M Vollmer; Stephen H Taplin; Erin M Keast; Scott Fields; Beverly B Green Journal: JAMA Intern Med Date: 2018-09-01 Impact factor: 21.873
Authors: Theodore R Levin; Douglas A Corley; Christopher D Jensen; Joanne E Schottinger; Virginia P Quinn; Ann G Zauber; Jeffrey K Lee; Wei K Zhao; Natalia Udaltsova; Nirupa R Ghai; Alexander T Lee; Charles P Quesenberry; Bruce H Fireman; Chyke A Doubeni Journal: Gastroenterology Date: 2018-07-19 Impact factor: 22.682
Authors: Alison T Brenner; Christina M Getrich; Michael Pignone; Robert L Rhyne; Richard M Hoffman; Andrew McWilliams; Brisa Urquieta de Hernandez; Mark A Weaver; Hazel Tapp; Khalil Harbi; Daniel Reuland Journal: Trials Date: 2014-07-08 Impact factor: 2.279
Authors: Melinda M Davis; Jennifer L Schneider; Amanda F Petrik; Edward J Miech; Brittany Younger; Anne L Escaron; Jennifer S Rivelli; Jamie H Thompson; Denis Nyongesa; Gloria D Coronado Journal: Ann Fam Med Date: 2022 Mar-Apr Impact factor: 5.166
Authors: Dana M Womack; Edward J Miech; Nicholas J Fox; Linus C Silvey; Anna M Somerville; Deborah H Eldredge; Linsey M Steege Journal: Appl Clin Inform Date: 2022-08-31 Impact factor: 2.762
Authors: Edward J Miech; Anthony J Perkins; Ying Zhang; Laura J Myers; Jason J Sico; Joanne Daggy; Dawn M Bravata Journal: BMJ Open Date: 2022-06-07 Impact factor: 3.006
Authors: Gloria D Coronado; Michael C Leo; Katrina Ramsey; Jennifer Coury; Amanda F Petrik; Mary Patzel; Erin S Kenzie; Jamie H Thompson; Erik Brodt; Raj Mummadi; Nancy Elder; Melinda M Davis Journal: Implement Sci Commun Date: 2022-04-13
Authors: Beverly B Green; Melissa L Anderson; Andrea J Cook; Jessica Chubak; Sharon Fuller; Richard T Meenan; Sally W Vernon Journal: J Gen Intern Med Date: 2021-05-28 Impact factor: 6.473